Skip to main content
TipRanks
Go Ultimate75% OFF

PhoenixBio Co., Ltd. (6190) Ratios

0 Followers

PhoenixBio Co., Ltd. Ratios

JP:6190's free cash flow for Q4 2025 was ¥0.00. For the 2025 fiscal year, JP:6190's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.

Financial ratios
RatiosMar 26Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio4.403.035.061.784.23
Quick Ratio3.582.443.991.503.64
Cash Ratio3.072.033.291.213.02
Solvency Ratio0.25-0.440.060.34-0.21
Operating Cash Flow Ratio0.18-0.13-0.190.220.04
Short-Term Operating Cash Flow Coverage0.31-0.41-0.440.320.53
Net Current Asset Value¥ 1.00B¥ 772.62M¥ 1.21B¥ 787.93M¥ 401.93M
Leverage Ratios
Debt-to-Assets Ratio0.220.240.270.370.47
Debt-to-Equity Ratio0.310.410.400.751.29
Debt-to-Capital Ratio0.240.290.290.430.56
Long-Term Debt-to-Capital Ratio0.080.140.140.000.52
Financial Leverage Ratio1.411.691.511.992.75
Debt Service Coverage Ratio0.49-2.230.300.59-9.41
Interest Coverage Ratio17.25-25.773.78165.51-176.07
Debt to Market Cap0.200.270.260.420.54
Interest Debt Per Share120.90141.08192.20333.55324.01
Net Debt to EBITDA-5.671.47-7.52-0.790.84
Profitability Margins
Gross Profit Margin75.95%71.89%69.67%73.28%54.94%
EBIT Margin5.29%-27.53%3.66%24.19%-29.59%
EBITDA Margin7.44%-25.70%5.13%25.30%-23.08%
Operating Profit Margin5.29%-8.77%0.64%23.94%-12.65%
Pretax Profit Margin8.40%-27.87%3.49%24.04%-29.66%
Net Profit Margin8.00%-28.91%1.54%23.23%-29.28%
Continuous Operations Profit Margin8.00%-28.91%1.54%23.23%-29.28%
Net Income Per EBT95.27%103.75%44.12%96.61%98.72%
EBT Per EBIT158.80%317.80%540.40%100.43%234.46%
Return on Assets (ROA)5.71%-19.29%0.97%16.34%-17.01%
Return on Equity (ROE)8.07%-32.64%1.47%32.57%-46.85%
Return on Capital Employed (ROCE)4.55%-7.75%0.48%29.35%-9.10%
Return on Invested Capital (ROIC)3.87%-6.91%0.19%18.55%-8.70%
Return on Tangible Assets5.75%-19.44%0.98%16.37%-17.02%
Earnings Yield7.00%-29.86%1.44%23.61%-22.42%
Efficiency Ratios
Receivables Turnover11.509.057.897.415.86
Payables Turnover27.7026.4740.2414.1816.02
Inventory Turnover1.221.301.151.552.31
Fixed Asset Turnover3.022.923.163.943.23
Asset Turnover0.710.670.630.700.58
Working Capital Turnover Ratio1.291.081.261.750.94
Cash Conversion Cycle316.96307.25353.32258.39197.41
Days of Sales Outstanding31.7340.3246.2749.2762.34
Days of Inventory Outstanding298.41280.71316.12234.87157.85
Days of Payables Outstanding13.1713.799.0725.7522.78
Operating Cycle330.14321.04362.39284.14220.19
Cash Flow Ratios
Operating Cash Flow Per Share16.94-18.05-20.9781.694.97
Free Cash Flow Per Share13.88-23.30-31.2278.052.92
Dividend Paid and CapEx Coverage Ratio5.54-3.44-2.0522.442.42
Capital Expenditure Coverage Ratio5.54-3.44-2.0522.442.42
Operating Cash Flow Coverage Ratio0.14-0.13-0.110.250.02
Operating Cash Flow to Sales Ratio0.04-0.05-0.050.130.01
Free Cash Flow Yield3.15%-6.31%-6.45%12.69%0.56%
Valuation Ratios
Price-to-Earnings (P/E) Ratio14.28-3.3569.394.23-4.46
Price-to-Sales (P/S) Ratio1.140.971.070.981.31
Price-to-Book (P/B) Ratio1.151.091.021.382.09
Price-to-Free Cash Flow (P/FCF) Ratio31.70-15.84-15.507.88179.73
Price-to-Operating Cash Flow Ratio25.97-20.44-23.087.53105.51
Price-to-Earnings Growth (PEG) Ratio-0.110.00-0.73-0.02-0.07
Enterprise Value Multiple9.68-2.2913.303.10-4.82
Enterprise Value1.13B908.45M1.17B1.66B1.47B
EV to EBITDA9.68-2.2913.303.10-4.82
EV to Sales0.720.590.680.781.11
EV to Free Cash Flow19.99-9.64-9.906.28153.07
EV to Operating Cash Flow16.38-12.44-14.756.0089.87
Tangible Book Value Per Share378.29333.07472.45444.30250.35
Shareholders’ Equity Per Share381.97337.58475.34445.84250.81
Tax and Other Ratios
Effective Tax Rate0.05-0.040.560.030.01
Revenue Per Share385.15381.09453.58625.29401.22
Net Income Per Share30.81-110.186.98145.23-117.50
Tax Burden0.951.040.440.970.99
Interest Burden1.591.010.950.991.00
Research & Development to Revenue0.120.180.120.100.17
SG&A to Revenue0.580.630.090.070.10
Stock-Based Compensation to Revenue0.000.000.000.010.01
Income Quality0.550.16-3.050.56-0.04

Currency in JPY